Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

Sanofi to acquire Translate Bio to develop mRNA tech across vaccines and therapeutics

Sanofi will acquire clinical-stage mRNA therapeutics company Translate Bio for $3.2bn.

Sartorius downplays threat of Chinese regulatory changes to single-use tech

Sartorius has expressed confidence that demand for single-use technologies will be unaffected by changes to the regulation of biologics in China.

Content provided by Thermo Fisher Scientific

Notes on compliance: Building the USP 71 sterility testing processes that support USP, EP and JP harmonized methods

Sterility testing is a crucial element of pharmaceutical manufacturing but testing for the absence of objectionable organisms in finished products is just the tip of the iceberg. Find out more

‘Some way to go’ before decision on Biogen Alzheimer’s drug, says UnitedHealth

There is “some way to go” before UnitedHealth Group has the clarity to make a coverage decision on Biogen’s Alzheimer’s disease drug Aduhelm, according to the CEO of the healthcare company.

Treg cell therapy showing promise in ALS trials: Coya Therapeutics

According to the neurodegenerative-disease-focused biotechnology firm, their research could bring hope to patients with amyotrophic lateral sclerosis.